“why would NWBO even consider a loan if they have arranged nondilutive financing for joint trials as promised by Powers?”
Maybe because Linda Powers explained at the ASM those deals would be announced when the deals were completed, and maybe the deals aren’t completed until approval (apparently this is what she meant by “cemented”), and maybe bears are attacking while nwbo is required to remain silent during the approval process.
This is more of the same. There doesn’t appear to be any coherent funding philosophy or strategy. The balance sheet is littered with ad hoc financial arrangements from both Penny-stock lenders and the company’s bench of angel investors. And unfortunately this new loan just fits that exact description. Will be interesting to read the Loan Agreement.
The window for incrementally buying shares is between December and into early next year in my opinion. I said this yesterday even before learning about the new loan, November is shaping up to be a rough month.